Affinage

ZYX

Zyxin · UniProt Q15942

Audit flag: ungrounded claim
Length
572 aa
Mass
61.3 kDa
Annotated
2026-06-11
14 papers in source corpus 10 papers cited in narrative 13 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 4/4 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

Zyxin (ZYX) is a LIM-domain cytoskeletal adaptor that localizes to mechanically loaded adhesion structures and stabilizes actin networks under tension, while also shuttling to the nucleus to couple mechanical input to gene expression (PMID:23427270, PMID:36384139). At focal adhesions it cooperates with VASP to assemble dense, uniformly polar actin bundles whose barbed ends orient toward the cell edge, defining a distinct layer of focal-adhesion architecture. In striated muscle its orthologue ZYX-1 concentrates at dense bodies/Z-discs and M-lines through interactions with α-actinin (ATN-1), vinculin (DEB-1), and the dystrophin-associated protein DYC-1, with localization dependent on α-actinin (PMID:18094057, PMID:23427270). Its tension-sensitive recruitment stabilizes junctional and synaptic F-actin against mechanical force during morphogenesis and at mechanosensory synapses, a function residing in the C-terminal LIM domains (PMID:25252943, PMID:36384139). Under oscillatory shear stress, endothelial zyxin acts as a mechanosensor that binds 14-3-3β to inhibit YAP Ser127 phosphorylation, promoting nuclear YAP translocation and inflammatory gene expression that drives atherosclerosis. Zyxin is embedded in cancer signaling as a transcriptionally regulated node acting downstream of ITGB1 through the FAK/AKT axis and upstream of STMN1 in tumor cell invasion (PMID:31949244, PMID:39143566). It also broadly restricts viral envelope fusion and entry across multiple virus families.

Mechanistic history

Synthesis pass · year-by-year structured walk · 11 steps
  1. 2002 Medium

    Established the first molecular partners of a zyxin orthologue, linking the LIM-domain protein ZYX-1 to germline RNA helicases and hinting at functions beyond adhesion.

    Evidence Yeast two-hybrid screen and GST pull-down in C. elegans

    PMID:12435362

    Open questions at the time
    • Functional consequence of the GLH interaction not defined
    • Relevance to vertebrate zyxin unknown
  2. 2007 Medium

    Placed ZYX-1 at the sarcomeric adhesion structure by mapping a short DYC-1 sequence sufficient for dense-body targeting, connecting zyxin to dystrophin-associated muscle architecture.

    Evidence Yeast two-hybrid, immunolocalization, and domain mapping in C. elegans muscle

    PMID:18094057

    Open questions at the time
    • Mechanical or signaling role at dense bodies not tested
    • No vertebrate confirmation
  3. 2013 High

    Defined ZYX-1 as a dynamic, peripherally associated component of muscle dense bodies and Z-discs that depends on α-actinin and shuttles to the nucleus, suggesting a mechanotransduction role.

    Evidence Yeast two-hybrid, live imaging, FRAP, and isoform-specific genetics in C. elegans

    PMID:23427270

    Open questions at the time
    • Nuclear targets of shuttled ZYX-1 unidentified
    • Mechanism distinguishing the two isoforms incomplete
  4. 2014 High

    Showed that zyxin stabilizes mechanosensory synapses against locomotion-induced force and localized this activity to the C-terminal LIM domains, separating force-stabilization from actin/α-actinin binding.

    Evidence Loss-of-function genetics, epistasis, and isoform rescue in C. elegans

    PMID:25252943

    Open questions at the time
    • Molecular partners of the LIM domains at synapses not identified
    • How LIM domains sense force not resolved
  5. 2020 Medium

    Identified ZYX as a pro-invasive node in cancer, placing it upstream of STMN1 and demonstrating a tumor-suppressive ZYX-derived peptide that engages TSP1, revealing both full-length and fragment-level functions.

    Evidence Knockdown/overexpression with RNA-seq, proteomics, and rescue in glioblastoma; peptide pull-down and functional assays in ovarian cancer

    PMID:31949244 PMID:32953725

    Open questions at the time
    • Mechanism by which ZYX regulates STMN1 levels unknown
    • Physiological relevance of ZYX36-58 peptide unclear
  6. 2022 High

    Demonstrated tension-dependent recruitment of zyxin to apical junctions and stress-fiber strain sites, establishing it as part of a force-sensitive system stabilizing junctional actin during morphogenesis.

    Evidence C. elegans genetics, imaging, epistasis with cadherin/catenin hypomorphs, and vertebrate stress-fiber strain-site recruitment assay

    PMID:36384139

    Open questions at the time
    • The force-sensing element within zyxin not molecularly defined
    • Link between junctional and focal-adhesion roles unresolved
  7. 2024 Medium

    Connected zyxin mechanosensing to transcription by showing it binds 14-3-3β to relieve YAP Ser127 phosphorylation, driving nuclear YAP and endothelial inflammation in atherosclerosis.

    Evidence Endothelial-specific knockout ApoE−/− mouse, disturbed-flow system, and co-IP/phosphorylation studies (preprint)

    Open questions at the time
    • Preprint, not peer-reviewed
    • Direct binding of zyxin to 14-3-3β versus indirect effect not fully distinguished
  8. 2024 Medium

    Positioned ZYX within the ITGB1/FAK/AKT signaling axis, showing it acts downstream of integrin β1 to drive EMT and suppress apoptosis in hepatocellular carcinoma.

    Evidence siRNA knockdown, overexpression rescue, xenograft, and pathway Western blots

    PMID:39143566

    Open questions at the time
    • Direct biochemical link between ZYX and FAK/AKT not shown
    • Whether effect requires zyxin's cytoskeletal localization untested
  9. 2025 Medium

    Resolved the structural output of zyxin-VASP cooperation at focal adhesions, showing assembly of uniformly polar actin bundles and a layered focal-adhesion architecture.

    Evidence CRISPR/Cas9 knockout, cryo-electron tomography, and live-cell imaging (preprint)

    Open questions at the time
    • Preprint, not peer-reviewed
    • Order of zyxin and VASP recruitment to nascent bundles unresolved
  10. 2025 Medium

    Revealed an unexpected broad antiviral function in which zyxin restricts viral envelope fusion and entry, potentially via effects on membrane properties.

    Evidence CRISPR/Cas9 knockout, cell-cell fusion and plaque assays, and bulk RNA-seq (preprint)

    Open questions at the time
    • Preprint, not peer-reviewed
    • Direct molecular mechanism linking zyxin to membrane fusion undefined
  11. 2025 Medium

    Extended ZYX's regulatory range as a transcriptionally controlled node, identifying lncRNA/HNRNPC/RARA-driven activation of ZYX that suppresses prostate cancer invasion and a TGF-β/SMAD-coupled role in acinar cell ferroptosis.

    Evidence RIP, reporter/ChIP-type analysis, and rescue in prostate cancer; molecular docking and overexpression epistasis in a pancreatitis mouse model

    PMID:40414075 PMID:41134509

    Open questions at the time
    • Ferroptosis link rests partly on computational docking
    • Apparently opposite invasion effects across cancer contexts unreconciled

Open questions

Synthesis pass · forward-looking unresolved questions
  • How zyxin's mechanosensitive LIM domains physically sense force and how this single adaptor coordinates its adhesion, transcriptional, antiviral, and context-dependent cancer roles remains unresolved.
  • No structural model of force-induced conformational change
  • Unifying mechanism across diverse functions not established

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 3 GO:0008092 cytoskeletal protein binding 2 GO:0140299 molecular sensor activity 2
Localization
GO:0005856 cytoskeleton 3 GO:0005634 nucleus 2
Pathway
R-HSA-1474244 Extracellular matrix organization 2 R-HSA-162582 Signal Transduction 2 R-HSA-1643685 Disease 2
Complex memberships
dense body/Z-discfocal adhesion

Evidence

Reading pass · 13 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2002 C. elegans ZYX-1 (zyxin orthologue) binds GLH germline RNA helicases, as demonstrated by yeast two-hybrid screening and independent GST pull-down assays. ZYX-1 is a LIM-domain protein most similar to vertebrate zyxin. Yeast two-hybrid screen; GST pull-down assay Developmental biology Medium 12435362
2007 C. elegans ZYX-1 interacts with DYC-1 (a dystrophin-associated protein) at dense bodies in muscle. The interaction was mapped to a conserved 19-amino-acid sequence in DYC-1 that is sufficient for dense-body targeting, placing ZYX-1 at the C. elegans sarcomeric adhesion structure. Yeast two-hybrid assay; immunolocalization; domain-mapping experiments Molecular biology of the cell Medium 18094057
2013 C. elegans ZYX-1 localizes to dense bodies/Z-discs and M-lines in striated body-wall muscle and shuttles into the nucleus, suggesting a signal-transduction role. ZYX-1 interacts with DEB-1/vinculin and ATN-1/α-actinin by yeast two-hybrid. Localization and dynamics at dense bodies depend on ATN-1. FRAP reveals high mobility of ZYX-1 at these structures, consistent with a peripheral, dynamic association. Two isoforms (ZYX-1a and ZYX-1b) play distinct roles in dystrophin-dependent muscle degeneration. Yeast two-hybrid; fluorescence microscopy; FRAP; isoform-specific analysis; C. elegans genetics Molecular biology of the cell High 23427270
2014 C. elegans ZYX-1 maintains mechanosensory synapse integrity against locomotion-induced mechanical forces in vivo. The synapse-stabilizing activity is mediated by the C-terminal LIM domains alone; the N-terminal domain (which binds α-actinin and ENA-VASP) is dispensable for this function. C. elegans genetics (loss-of-function mutants); locomotion suppression epistasis; isoform rescue experiments Development (Cambridge, England) High 25252943
2020 ZYX promotes invasion of human glioblastoma cells; ZYX loss reduces invasion. RNA-seq and mass spectrometry identified STMN1 as a downstream target whose mRNA and protein levels are positively regulated by ZYX. STMN1 rescues the invasion deficit caused by ZYX knockdown, placing ZYX upstream of STMN1 in a pro-invasive axis. ZYX knockdown/overexpression; RNA-seq; mass spectrometry; STMN1 rescue experiments; in vitro invasion assays; in vivo experiments Laboratory investigation Medium 31949244
2020 A peptide fragment of ZYX (ZYX36-58) inhibits invasion and migration and promotes apoptosis of ovarian cancer cells. Mechanistically, ZYX36-58 binds and up-regulates the antiangiogenic/tumor-suppressive protein thrombospondin-1 (TSP1), as shown by peptide pull-down assay. Peptide pull-down assay; CCK8, transwell, wound-healing, and flow cytometry assays; RNA-seq Annals of translational medicine Medium 32953725
2022 C. elegans ZYX-1/Zyxin is recruited to apical junctions in dorsal and ventral epidermal cells during embryonic elongation when junctions are under tension. Its LCR region is recruited to stress fiber strain sites in cultured vertebrate cells. Loss of ZYX-1 causes junctional F-actin defects and enhances morphogenetic defects in cadherin/catenin complex hypomorphs, establishing ZYX-1 as part of a tension-sensitive system that stabilizes junctional actin during morphogenesis. C. elegans genetics; fluorescence imaging; genetic epistasis with CCC hypomorphs; vertebrate cell culture SFSS recruitment assay Current biology : CB High 36384139
2024 Endothelial zyxin acts as a mechanosensor under oscillatory shear stress (OSS) and promotes YAP nuclear translocation and endothelial inflammation. Mechanistically, zyxin interacts with 14-3-3β and inhibits 14-3-3β-facilitated phosphorylation of YAP at Serine 127, thereby reducing cytoplasmic retention of YAP and allowing nuclear YAP-driven inflammatory gene expression. EC-specific zyxin knockout in ApoE−/− mice reduces OSS-induced atherosclerosis. Endothelial cell-specific knockout mouse model (ZyxiniECKO ApoE−/−); disturbed-flow in vitro system; mechanistic co-immunoprecipitation/interaction studies with 14-3-3β and YAP; phosphorylation analysis bioRxiv (preprint)preprint Medium
2024 ZYX acts downstream of ITGB1 in hepatocellular carcinoma cells. ITGB1 knockdown suppresses the FAK/AKT pathway; ZYX knockdown phenocopies this and also suppresses the FAK/AKT pathway. ZYX knockdown inhibits the growth-promoting effect of ITGB1 overexpression, while ZYX knockdown has no effect on ITGB1 expression, placing ZYX downstream of ITGB1 in the ITGB1/ZYX/FAK/AKT axis governing EMT and apoptosis. siRNA knockdown; overexpression rescue; in vivo xenograft model; Western blot for pathway components Cancer cell international Medium 39143566
2025 Zyxin restricts viral envelope fusion and entry broadly across multiple virus families (HSV-1, PRV, paramyxovirus, rhabdovirus). Zyxin-KO cells show enhanced cell-cell fusion and larger viral plaques. Bulk RNA-seq of zyxin-KO cells identified altered expression of genes related to membrane potential, extracellular matrix organization, and MAPK cascade regulation, suggesting zyxin influences membrane properties relevant to viral fusion. CRISPR/Cas9 knockout; quantitative cell-cell fusion assay; plaque assay; bulk RNA-seq bioRxiv (preprint)preprint Medium
2025 Zyxin and VASP cooperate to assemble dense, uniformly polar actin bundles at focal adhesions with barbed ends oriented toward the cell edge. CRISPR/Cas9 knockout of zyxin and/or VASP alters FA morphology and dynamics. Cryo-ET resolves the polarity of actin filaments at FAs; the tropomyosin-decorated dorsal actin layer is unaffected by zyxin/VASP loss, revealing layered FA architecture. CRISPR/Cas9 knockout; cryo-electron tomography; live-cell imaging of FA dynamics bioRxiv (preprint)preprint Medium
2025 RAD51-AS1 lncRNA activates ZYX transcription via the HNRNPC/RARA axis in prostate cancer cells. RAD51-AS1 recruits HNRNPC to bind pre-RARA mRNA, positively modulating RARA expression; RARA in turn activates ZYX transcription. This pathway suppresses PCa cell migration and invasion, and rescue assays confirm RAD51-AS1 acts through ZYX. RT-qPCR; RIP/RNA binding assays; transcription reporter/ChIP-type analysis; knockdown/overexpression rescue assays; functional migration/invasion assays Discover oncology Medium 41134509
2025 Coumestrol (CMS) binds ZYX directly (molecular docking supported by cell biology), down-regulates ZYX expression, and reduces TGF-β/SMAD pathway activity, thereby inhibiting ferroptosis in pancreatic acinar cells. ZYX overexpression counteracts the inhibitory effects of CMS on TGF-β/SMAD signaling and ferroptosis, placing ZYX upstream of TGF-β/SMAD in acinar cell ferroptosis. Molecular docking; WGCNA/network pharmacology; ZYX overexpression epistasis; in vivo caerulein-induced AP mouse model; ferroptosis assays International immunopharmacology Low 40414075

Source papers

Stage 0 corpus · 14 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2002 The GLH proteins, Caenorhabditis elegans P granule components, associate with CSN-5 and KGB-1, proteins necessary for fertility, and with ZYX-1, a predicted cytoskeletal protein. Developmental biology 60 12435362
2024 Anti-diabetic and anti-inflammatory indole diterpenes from the marine-derived fungus Penicillium sp. ZYX-Z-143. Bioorganic chemistry 23 38387395
2020 Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme. Laboratory investigation; a journal of technical methods and pathology 21 31949244
2013 ZYX-1, the unique zyxin protein of Caenorhabditis elegans, is involved in dystrophin-dependent muscle degeneration. Molecular biology of the cell 20 23427270
2014 The conserved LIM domain-containing focal adhesion protein ZYX-1 regulates synapse maintenance in Caenorhabditis elegans. Development (Cambridge, England) 19 25252943
2007 DYC-1, a protein functionally linked to dystrophin in Caenorhabditis elegans is associated with the dense body, where it interacts with the muscle LIM domain protein ZYX-1. Molecular biology of the cell 19 18094057
2011 QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells. Cancer science 14 21920000
2009 Association of ZYX polymorphisms with carcass and meat quality traits in commercial pigs. Meat science 9 20374769
2022 TES-1/Tes and ZYX-1/Zyxin protect junctional actin networks under tension during epidermal morphogenesis in the C. elegans embryo. Current biology : CB 7 36384139
2020 Peptidome characterization of ovarian cancer serum and the identification of tumor suppressive peptide ZYX36-58. Annals of translational medicine 6 32953725
2024 Persteroid, a new steroid from the marine-derived fungus Penicillium sp. ZYX-Z-143. Natural product research 5 39225394
2024 Does rAj-Tspin, a novel peptide from A. japonicus, exert antihepatocellular carcinoma effects via the ITGB1/ZYX/FAK/AKT signaling pathway? Cancer cell international 1 39143566
2025 Network pharmacology analysis reveals that coumestrol targets ZYX to inhibit ferroptosis and alleviate acute pancreatitis. International immunopharmacology 0 40414075
2025 RAD51-AS1 inhibits the migration and invasion of prostate cancer cells by up-regulating RARA to activate ZYX transcription. Discover oncology 0 41134509

Missed literature

Know a paper Affinage missed for ZYX? Flag it for the maintainers and the community.

No submissions yet.